English | Español

Pharmaceuticals

+ Pharmaceuticals
Patient Daily | Jul 27, 2026

Argenx to acquire Forte Biosciences for $2.2 billion in immunology expansion
+ Pharmaceuticals
Patient Daily | Jul 27, 2026

Study links gut microbial pathway and dietary nutrient to atrial fibrillation risk
+ Pharmaceuticals
Patient Daily | Jul 27, 2026

USC-led study finds blood tests effective for Alzheimer's detection in Down syndrome patients
+ Pharmaceuticals
Patient Daily | Jul 27, 2026

Sarepta Therapeutics appoints Michael Severino as CEO, replacing Doug Ingram
+ Pharmaceuticals
Patient Daily | Jul 27, 2026

Researchers identify rare BTK mutation linked to resistance in blood cancer therapies
+ Pharmaceuticals
Patient Daily | Jul 27, 2026

Brighton station installs Auracast technology to assist passengers with hearing loss
+ Pharmaceuticals
Patient Daily | Jul 27, 2026

Wearable fingertip patch tracks Parkinson's medication through sweat, UC San Diego team says
+ Pharmaceuticals
Patient Daily | Jul 27, 2026

Researchers develop plant-based lignin material for potential bone regeneration therapies

Trending
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Regulatory
M. Y. Bailey | Aug 7, 2026

PhRMA's Zirkelbach: 340B program has changed dramatically with 'little transparency into how patients benefit'
Patient Daily reports | Aug 10, 2026

SoCal Breathe Free warns persistent sinus symptoms may signal chronic inflammation